PeptideDB

Linoleic Acid Amide

CAS No.: 3999-01-7

Linoleic Acid Amide (Linoleamide) is derived from linoleic acid and regulates Ca2+ flux by inhibiting the sarco/endoplas
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Linoleic Acid Amide (Linoleamide) is derived from linoleic acid and regulates Ca2+ flux by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase.
Synonyms 9,12-Octadecadienamide, Linoleamide, Linoleic Acid Amide
molecular weight 279.46
Molecular formula C18H33NO
CAS 3999-01-7
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMF: > 14 mg/mL DMSO: 18mg/mL (64.4mM) Ethanol: > 22 mg/mL
References 1. Farrell, E.K., Chen, Y., Barazanji, M., et al. Primary fatty acid amide metabolism: Conversion of fatty acids and an ethanolamine in N18TG2 and SCP cells. J. Lipid. Res. 53(2), 247-256 (2012). 2. Yamamaoto, S., Takehara, M., and Ushimaru, M. Inhibitory action of linoleamide and oleamide toward sarco/endoplasmic reticulum Ca2+-ATPase. Biochim. Biophys. Acta 1861(1 Pt A), 3399-3405 (2016).